Helix BioMedix Email Format
Biotechnology ResearchWashington, United States11-50 Employees
Helix BioMedix is a biotechnology company focused on developing bioactive peptides derived from natural cellular sequences for topical use. Its product approach centers on a library of proprietary peptide sequences intended to address dermatological conditions such as acne, rosacea, fungal infections, and MRSA, with the aim of offering health and safety benefits through advanced small-molecule peptide technology. Based in Bothell, Washington, the company operates within the biotechnology research sector and pursues applications that support clinical practice and patient well-being through topically applied treatments. The organization has a modest footprint, with a level of scale typical for specialized biotech firms, and has pursued leadership changes noted in industry coverage. In 2017, the firm announced a promotion in its executive leadership, reflecting ongoing internal development and governance adjustments as part of its operations.